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One of the known mechanisms of cerebral malaria (CM)
is the sequestration, within brain microvessels, of Plasmo-
dium falciparum-parasitized red blood cells (PRBC), but
also of leucocytes and platelets. Besides, CM is character-
ized by an overproduction of pro-inflammatory
cytokines, inducing endothelial activation. This activation
notably leads to the overexpression of adhesion mole-
cules and to the release of microparticles, derived from
various cell types within the vascular compartment.
Microparticles are submicronic membranous elements
carrying on their surface proteins from their cell of origin,
which bestow on them specific biological properties.
Because platelet-derived microparticles (PMP) represent
the majority of circulating microparticles and because
platelets have been shown to modulate PRBC cytoadher-
ence, we analyzed the potential role of PMP in this cytoad-
herence.
To this aim, we used an in vitro model of human CM
involving co-cultures of PMP, purified from A23187-acti-
vated platelets, enriched late-trophozoïte PRBC from the
IP-PAM strain, and the human brain microvascular
endothelial cell line HBEC-5i.
We demonstrated by confocal microscopy and flow
cytometry that PMP both bound to and were internalized
by HBEC-5i, and as a consequence enhanced the expres-
sion of adhesion receptors involved in CM pathogenesis,
such as ICAM-1 and VCAM-1. Furthermore, we showed
that PMP were able to bind to PRBC thereby transferring
platelet antigens to PRBC surface. PMP binding to PRBC
was not affected by temperature or phosphatidylserine
blockade by annexin V but was significantly reduced
when PRBC were treated with trypsin or when PRBC were
incubated with PMP in the presence of antibodies against
platelet CD31 (PECAM-1) and CD36 (GPIV). Lastly, PMP,
while interacting with the two other cell types, dramati-
cally increased PRBC cytoadherence to both resting and
TNF-prestimulated HBEC-5i.
PMP thus appear to be an important element in RBC
sequestration and in endothelial pathology, raising a
novel mechanism by which PMP may participate in CM
pathogenesis.
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